Search results
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 2 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 3 days agoYesafili is a trademark of Biosimilars Newco, a Biocon Biologics company. Opuviz is a trademark of...
1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 6 hours agoSo by any standard, if these projections work out, Ocugen is severely undervalued. And that's...
Astaxanthin Is the Deep Sea Supplement Experts Say Improves Longevity + Benefits Heart and Vision
First for Women via Yahoo News· 3 days agoIf you’d prefer a naturally-sourced supplement (which Dr. Shimek recommends), try Micro Ingredients...
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....
WTRF Wheeling· 3 days agoBiocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration ...
6 Everyday Habits That You Didn't Know Are Ruining Your Vision
CNET· 3 days agoIf you've never experienced any issues with your vision or your eye health for that matter, then you...
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Investing.com· 4 days agoBiocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
FDA approves 2 Eylea biosimilars
Becker’s Hospital Review· 4 days agoThe FDA granted approval to Biocon Biologics' drug Yesafili and Samsung Bioepis and Biogen's drug Opuviz, the agency announced May 20. The two drugs are biosimilars for Eylea, an injection made ...
Victoria Eye Center Notifies Over 80k of Recent Data Breach | JD Supra
JD Supra· 2 days agoOn May 13, 2024, Victoria Eye Center / Victoria Surgery Center / Victoria Vision Center (“VEC”) filed a notice of data breach with the Attorney General of Maine after discovering that files ...
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $5.50 Average Price Target from Analysts
ETF DAILY NEWS· 16 hours agoShares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) have received an average recommendation of “Reduce” from the seven analysts that are currently covering the company, Marketbeat.com ...